Highly
infiltrative and invasive glioma cells obscure the boundary
between tumor and normal brain tissue, making it extremely difficult
to precisely diagnose and completely remove. The combination of multimodal
imaging with effective treatments to diagnose precisely and guide
surgery and therapy accurately is desperately needed for glioma in
the brain. Here, we report a biomimetic catalase-integrated-albumin
phototheranostic nanoprobe (ICG/AuNR@BCNP) to realize multimodal imaging,
amplify phototherapy, and guide surgery for glioma after penetrating
the blood–brain barrier, accumulating into deep-seated glioma via albumin-binding protein mediated transportation. The
phototheranostic nanoprobe enabled fluorescence, photoacoustic, and
infrared thermal imaging with desirable detecting depth and high signal-to-background
ratio for clearly differentiating brain tumors from surrounding tissues.
Meanwhile, the nanoprobe could effectively induce local hyperthermia
and promote the level of singlet oxygen based on alleviated hypoxic
glioma microenvironment by decomposing endogenous hydrogen peroxide
to oxygen to amplify phototherapy. Thus, significant inhibition of
glioma growth, extended survival time, alleviated tumor hypoxia, improved
apoptosis, and antiangiogenesis effects were exhibited in several
animal models including the periphery and the brain through intravenous
or intratumoral injection, meanwhile with low toxicity to normal tissue.
The phototherapy was also guided by the assistance of external bioluminescence,
magnetic resonance, and positron emission tomography imaging. Moreover,
the nanoprobe could accurately guide the glioma resection. These results
suggest that the phototheranostic nanoprobe is a promising nanoplatform
specifically for glioma to achieve multimodal diagnosis, effective
phototherapy, and accurate imaging-guided surgery.